In a world first, ophthalmology experts at Flinders University will determine the effectiveness and suitability of using SLT as an early intervention to prevent the onset of visual loss from glaucoma.
Researchers have developed a gene therapy that has lowered intraocular pressure (IOP) in animal models, suggesting that glaucoma can be readily treated with gene therapy–based methods, paving the way for deployment in clinical trials.
Glaucoma detection and monitoring have reached new horizons with the pioneering application of hyperspectral imaging of cellular autofluorescence.
Macquarie University ophthalmology researchers have discovered a link between the protein neuroserpin and glaucoma and developed a technique for a gene therapy that could help treat the world’s leading cause of irreversible blindness.
More than 5,000 Australians have already volunteered to take part in the QIMR Berghofer Genetics of Glaucoma study, but the researchers are appealing for more participants.
Researchers have identified a therapeutic target that could lead to more effective treatment of glaucoma.
An opportunity to help further research into treatments for open-angle glaucoma is now open to adults who have been diagnosed with this condition. Volunteers will play an important role in this study by enabling researchers to study the safety and effectiveness of the investigational drug when it is injected into the eye.
Five Australians are among an international team of scientists who have discovered a new gene mutation that may be a root cause of severe cases of childhood glaucoma.
The concept of delivering a drug to protect retinal ganglion cells (RGCs) is not something that is currently done clinically, but as a complement to IOP lowering, may be an important glaucoma management tool.